2024-11-01 2025-12-31 2025-12-31 false 10806949 RHEAL SUPERFOODS LTD 47910Retail sale via mail order houses or via Internet iso4217:GBP xbrli:pure 108069492024-11-01 108069492025-12-31 108069492024-11-01 2025-12-31 10806949bus:SmallEntities2024-11-01 2025-12-31 10806949bus:AuditExempt-NoAccountantsReport2024-11-01 2025-12-31 10806949bus:FullAccounts2024-11-01 2025-12-31 10806949core:WithinOneYear2025-12-31 10806949core:AfterOneYear2025-12-31 10806949core:WithinOneYear2024-11-01 2025-12-31 10806949core:AfterOneYear2024-11-01 2025-12-31 10806949core:CurrentFinancialInstruments2025-12-31 10806949core:Non-currentFinancialInstruments2025-12-31 10806949core:CurrentFinancialInstruments2024-11-01 2025-12-31 10806949core:Non-currentFinancialInstruments2024-11-01 2025-12-31 10806949core:LandBuildings2024-11-01 2025-12-31 10806949core:FurnitureFittings2024-11-01 2025-12-31 10806949core:OfficeEquipment2024-11-01 2025-12-31 10806949core:Vehicles2024-11-01 2025-12-31 10806949core:PlantMachinery2024-11-01 2025-12-31 10806949core:OtherPropertyPlantEquipment2024-11-01 2025-12-31 10806949core:LandBuildings2025-12-31 10806949core:PlantMachinery2025-12-31 10806949core:Vehicles2025-12-31 10806949core:FurnitureFittings2025-12-31 10806949core:OfficeEquipment2025-12-31 10806949core:OtherPropertyPlantEquipment2025-12-31 10806949core:Right-of-useAssets2024-11-01 2025-12-31 10806949core:Right-of-useAssets2025-12-31 10806949core:Goodwill2024-11-01 2025-12-31 10806949core:PatentsTrademarksLicencesConcessionsSimilar2024-11-01 2025-12-31 10806949core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-11-01 2025-12-31 10806949core:OtherResidualIntangibleAssets2024-11-01 2025-12-31 10806949core:Goodwill2025-12-31 10806949core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-31 10806949core:PatentsTrademarksLicencesConcessionsSimilar2025-12-31 10806949core:OtherResidualIntangibleAssets2025-12-31 10806949dpl:CostSales2024-11-01 2025-12-31 10806949dpl:AdministrativeExpenses2024-11-01 2025-12-31 10806949dpl:DistributionCosts2024-11-01 2025-12-3110806949core:ShareCapital2025-12-31 10806949core:SharePremium2025-12-31 10806949core:RevaluationReserve2025-12-31 10806949core:OtherReservesSubtotal2025-12-31 10806949core:ShareCapitalPreferenceShares2025-12-31 10806949core:CapitalRedemptionReserve2025-12-31 10806949core:OtherCapitalReserve2025-12-31 10806949core:RetainedEarningsAccumulatedLosses2025-12-3110806949core:ShareCapital2024-11-01 2025-12-31 10806949core:SharePremium2024-11-01 2025-12-31 10806949core:RevaluationReserve2024-11-01 2025-12-31 10806949core:OtherReservesSubtotal2024-11-01 2025-12-31 10806949core:RetainedEarningsAccumulatedLosses2024-11-01 2025-12-311080694912024-11-01 2025-12-31 1080694922024-11-01 2025-12-3110806949core:ShareCapital12024-11-01 2025-12-31 10806949core:ShareCapital22024-11-01 2025-12-3110806949core:SharePremium12024-11-01 2025-12-31 10806949core:SharePremium22024-11-01 2025-12-3110806949core:RevaluationReserve12024-11-01 2025-12-31 10806949core:RevaluationReserve22024-11-01 2025-12-3110806949core:RetainedEarningsAccumulatedLosses12024-11-01 2025-12-31 10806949core:RetainedEarningsAccumulatedLosses22024-11-01 2025-12-311080694912024-11-01 2025-12-3110806949core:Non-currentFinancialInstrumentscore:CostValuation2024-11-01 10806949core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3110806949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3110806949core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-11-01 10806949core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-12-31 10806949core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-31 10806949core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-12-3110806949core:Non-currentFinancialInstruments2025-12-31 10806949core:Non-currentFinancialInstruments2024-10-31108069492023-11-01 108069492024-10-31 108069492023-11-01 2024-10-31 10806949core:WithinOneYear2024-10-31 10806949core:AfterOneYear2024-10-31 10806949core:CurrentFinancialInstruments2024-10-31 10806949core:Non-currentFinancialInstruments2024-10-31 10806949core:LandBuildings2024-10-31 10806949core:PlantMachinery2024-10-31 10806949core:Vehicles2024-10-31 10806949core:FurnitureFittings2024-10-31 10806949core:OfficeEquipment2024-10-31 10806949core:OtherPropertyPlantEquipment2024-10-31 10806949core:Right-of-useAssets2024-10-31 10806949core:Goodwill2024-10-31 10806949core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-10-31 10806949core:PatentsTrademarksLicencesConcessionsSimilar2024-10-31 10806949core:OtherResidualIntangibleAssets2024-10-31 10806949dpl:AdministrativeExpenses2023-11-01 2024-10-3110806949core:ShareCapital2024-10-31 10806949core:SharePremium2024-10-31 10806949core:RevaluationReserve2024-10-31 10806949core:OtherReservesSubtotal2024-10-31 10806949core:ShareCapitalPreferenceShares2024-10-31 10806949core:CapitalRedemptionReserve2024-10-31 10806949core:OtherCapitalReserve2024-10-31 10806949core:RetainedEarningsAccumulatedLosses2024-10-3110806949core:RetainedEarningsAccumulatedLosses2023-11-01 10806949core:ShareCapital2023-11-01 10806949core:SharePremium2023-11-01 10806949core:RevaluationReserve2023-11-01 10806949core:ShareCapital2023-11-01 2024-10-31 10806949core:SharePremium2023-11-01 2024-10-31 10806949core:RevaluationReserve2023-11-01 2024-10-31 10806949core:OtherReservesSubtotal2023-11-01 2024-10-31 10806949core:RetainedEarningsAccumulatedLosses2023-11-01 2024-10-311080694912023-11-01 2024-10-31 1080694922023-11-01 2024-10-3110806949core:ShareCapital12023-11-01 2024-10-31 10806949core:ShareCapital22023-11-01 2024-10-3110806949core:SharePremium12023-11-01 2024-10-31 10806949core:SharePremium22023-11-01 2024-10-3110806949core:RevaluationReserve12023-11-01 2024-10-31 10806949core:RevaluationReserve22023-11-01 2024-10-3110806949core:RetainedEarningsAccumulatedLosses12023-11-01 2024-10-31 10806949core:RetainedEarningsAccumulatedLosses22023-11-01 2024-10-3110806949bus:Director12024-11-01 2025-12-3110806949bus:Director22024-11-01 2025-12-3110806949bus:PrivateLimitedCompanyLtd2024-11-01 2025-12-31
RHEAL SUPERFOODS LTD
Unaudited Financial Statements
for the period ended 31 December 2025
Company registration number 10806949
(England and Wales)

Company Information

For the period 1 November 2024 to 31 December 2025
Directors Ali, Sean
Bailey, Charlotte

Registered office Unit Tb29 Turbine Way
Turbine Business Park
Sunderland
SR5 3NZ

Registered number 10806949

Accountant Lodestar Accounting Limited
17 Wigginton Road
England
B79 8RH

Statement of Financial Position

As at 31 December 2025
Notes
31 Dec 2025
31 Oct 2024
£
£
£
£
Fixed assets
Intangible assets
4
7,473
8,878
Tangible assets
5
147,465
206,125
Investments
6
7
7
154,945
215,010
Current assets
Stocks
3,901,001
4,323,889
Debtors
1,216,293
1,406,549
Cash at bank and in hand
155,831
462,506
5,273,125
6,192,944
Creditors
Amounts falling due within one year
7
(1,967,837)
(1,862,302)
(1,967,837)
(1,862,302)
Net current assets (liabilities)
3,305,288
4,330,642
Total assets less current liabilities
3,460,233
4,545,652
Creditors
Amounts falling due after one year
(1,028,238)
(11,087)
(1,028,238)
(11,087)
Net assets (liabilities)
2,431,995
4,534,565
Capital and reserves
Other reserves
4,557,515
2,865,830
Profit and loss account
(2,125,520)
1,668,735
Total equity
2,431,995
4,534,565

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 23 September 2026 and are signed on its behalf by:

Ali, Sean
Ali, Sean
Director

Company registration number 10806949

Notes to the Financial Statements

For the period 1 November 2024 to 31 December 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Revenue from sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

2.3. Employee benefits

Contributions to defined contribution plans are expensed in the period to which they relate.

2.4. Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

2.5. Intangible assets

Intangible assets are amortised over their estimated useful life on a straight line basis.

2.6. Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Rate
Method
%
Plant and machinery
25
Reducing balance
Office and computer equipment
33
Reducing balance

2.7. Investments

Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2.8. Stocks and work in progress

Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

3. Employees

The average number of employees during the year was 42 (2024: 39).

4. Intangible assets

Other intangibles
Total
£
£
Cost
At 1 November 2024
12,041
12,041
At 31 December 2025
12,041
12,041
Amortisation and impairment
At 1 November 2024
3,163
3,163
Other charges
1,405
1,405
At 31 December 2025
4,568
4,568
Net book value
At 31 December 2025
7,473
7,473
At 31 October 2024
8,878
8,878

5. Tangible fixed assets

Fixtures and fittings
Office equipment
Other tangible assets
Total
£
£
£
£
Cost
At 1 November 2024
142,371
215,359
20,818
378,548
Additions
1,500
7,388
-
8,888
At 31 December 2025
143,871
222,747
20,818
387,436
Depreciation and impairment
At 1 November 2024
54,185
115,347
2,891
172,423
Charge for the period
25,784
39,740
2,024
67,548
At 31 December 2025
79,969
155,087
4,915
239,971
Net book value
At 31 December 2025
63,902
67,660
15,903
147,465
At 31 October 2024
88,186
100,012
17,927
206,125

6. Fixed asset investments

Other investments
Total
£
£
Cost
At 1 November 2024
7
7
At 31 December 2025
7
7
Impairment
At 31 December 2025
-
-
Net book value
At 31 December 2025
7
7
At 31 October 2024
7
7

Rheal Superfoods Limited owns 100% of the issued share capital of Rheal Inc, a company registered in Delaware USA. Its registered office is 1209 Orange Street, Wilmington, New Castle, Delaware 19801.

7. Creditors due within one year

31 Dec 2025
31 Oct 2024
£
£
Bank loans and overdrafts
5,779
10,648
Trade creditors
1,630,068
1,502,340
Other creditors
58,565
6,609
Taxation and social security
59,947
30,273
Accruals and deferred income
213,478
312,432
Total
1,967,837
1,862,302